CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 64 enrolled
Drug / intervention
Vit Ddrug
Likely dose
Vit D 50.000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03986268
NCT03986268N/ACompleted
CompareCT.gov

The Effect of Vitamin D Replacement Therapy on Pathological Response in Breast Cancer Patients Treated With Neoadjuvant Therapy

Florence Nightingale Hospital, Istanbul·interventional·Posted Jun 14, 2019·Updated Feb 22, 2024

In Brief

A clinical study evaluating Vit D for Vitamin D Deficiency and 2 related conditions. Completed, enrolled 64 participants across 1 site.

Detailed Summary

The aim of the study is to evaluate the relationship between the vitamin D replacement and pathological response in patients undergoing neoadjuvant therapy according to different molecular sub types. Because of no study evaluating pathological response to neoadjuvant therapy with vitamin D replacement in patients with breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVitamin D Deficiency, Chemotherapy Effect, Pathology
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 14, 2019
Enrollment StartMay 10, 2019
Primary CompletionDec 10, 2020
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 7.0 years ago

Interventions

Vit Ddrug

The aim of this study is investigating pathologic response to neoadjuvant therapy if we give replacement therapy with vitamin D3 50.000 IU weekly dosage concurrent with chemotherapy in breast cancer patients.